0001656472-23-000153.txt : 20231215 0001656472-23-000153.hdr.sgml : 20231215 20231215171206 ACCESSION NUMBER: 0001656472-23-000153 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230512 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weigensberg Arye CENTRAL INDEX KEY: 0001937121 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 231491312 MAIL ADDRESS: STREET 1: 111 PETER STREET, SUITE 300 CITY: TORONTO STATE: A6 ZIP: MV5 2H1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 4 1 wk-form4_1702678313.xml FORM 4 X0508 4 2023-05-12 0 0001656472 Cronos Group Inc. CRON 0001937121 Weigensberg Arye 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2H1 ONTARIO, CANADA 0 1 0 0 See Remarks 0 COMMON SHARES 2023-05-12 4 M 0 9012 0 A 16049 D COMMON SHARES 2023-05-25 4 M 0 3972 0 A 20021 D COMMON SHARES 2023-12-13 4 M 0 6421 0 A 26442 D RESTRICTED STOCK UNITS 2023-05-12 4 M 0 9012 0 D COMMON SHARES 9012 119479 D RESTRICTED STOCK UNITS 2023-05-25 4 M 0 3972 0 D COMMON SHARES 3972 115507 D RESTRICTED STOCK UNITS 2023-12-13 4 M 0 6421 0 D COMMON SHARES 6421 109086 D Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc. On May 12, 2022, the reporting person was granted 27,040 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On May 25, 2021, the reporting person was granted 11,917 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On December 13, 2022, the reporting person was granted 19,266 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Senior Vice President, Head of Research and Development /s/ Aaron B. Werner, as attorney-in-fact for Arye Weigensberg 2023-12-15